SCHEMBL27879166

SCHEMBL27879166

Cc1ccc(-c2nc(C(=O)O)c(-c3ccc(F)c(Cl)c3)n2-c2cc(Cl)ccc2C)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 7/20 0.69
SMN1; SMN2 Q16637 2/20 0.41
MARS1 P56192 1/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
GABRA2 P47869 2/20 0.40
GABRB2 P47870 2/20 0.40
KMO O15229 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
DHODH Q02127 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
HTT P42858 3/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
RAB9A P51151 1/20 0.38
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27862924 0.93 MDM2 (0.66) MDM2SMN1; SMN2MARS1GABRA2GABRB2
SCHEMBL9893692 0.93 MDM2 (0.68) MDM2SMN1; SMN2MARS1TP53POLB
SCHEMBL9894206 0.92 MDM2 (0.83) MDM2SMN1; SMN2MARS1TP53POLB
SCHEMBL9894045 0.91 MDM2 (0.82) MDM2MARS1GABRA2GABRB2KMO
SCHEMBL27879169 0.89 MDM2 (0.69) MDM2SMN1; SMN2MARS1TP53KMO
SCHEMBL9893866 0.88 MDM2 (0.62) MDM2SMN1; SMN2MARS1TP53POLB
SCHEMBL1436973 0.88 MDM2 (0.89) MDM2SMN1; SMN2TP53POLBGABRA2
SCHEMBL1437240 0.86 MDM2 (0.59) MDM2SMN1; SMN2MARS1TP53POLB
SCHEMBL9893785 0.85 MDM2 (0.72) MDM2MARS1GABRA2GABRB2KMO
SCHEMBL28796347 0.85 MDM2 (0.88) MDM2KMOLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102574785-A Tetra-substituted heteroaryl compounds and their use as MDM2 and/or MDM4 modulators NOVARTIS AG 2012-07-11 CN disclosed